BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2256711)

  • 1. Accumulation of erythrocyte nucleotides and their pattern in lead workers.
    Sakai T; Araki T; Ushio K
    Arch Environ Health; 1990; 45(5):273-7. PubMed ID: 2256711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte nucleotides in lead workers.
    Ichiba M; Tomokuni K; Mori K
    Int Arch Occup Environ Health; 1992; 63(6):419-21. PubMed ID: 1544691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
    Ichiba M; Tomokuni K
    Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte nucleotides in children--increased blood lead and cytidine triphosphate.
    Angle CR; McIntire MS; Swanson MS; Stohs SJ
    Pediatr Res; 1982 Apr; 16(4 Pt 1):331-4. PubMed ID: 7079004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal erythrocyte pyrimidine nucleotides in uremic subjects.
    Angle CR; Swanson MS; Stohs SJ; Markin RS
    Nephron; 1985; 39(3):169-74. PubMed ID: 2983249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lead exposure in workers at a lead-acid battery factory in Korea: with focus on activity of erythrocyte pyrimidine 5'-nucleotidase (P5N).
    Kim Y; Harada K; Ohmori S; Lee BK; Miura H; Ueda A
    Occup Environ Med; 1995 Jul; 52(7):484-8. PubMed ID: 7670624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reviews on biochemical markers of lead exposure with special emphasis on heme and nucleotide metabolisms].
    Sakai T
    Sangyo Eiseigaku Zasshi; 1995 Mar; 37(2):99-112. PubMed ID: 7749999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of erythrocyte nucleotides in pyrimidine 5'-nucleotidase deficiency.
    Torrance JD; Whittaker D
    Br J Haematol; 1979 Nov; 43(3):423-34. PubMed ID: 497119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte nucleotides from control and lead-treated rabbits.
    Swanson MS; Angle CR; Stohs SJ; Rovang KS
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):353-61. PubMed ID: 6245437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure.
    Sakai T; Ushio K
    Br J Ind Med; 1986 Dec; 43(12):839-44. PubMed ID: 3026435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pyrimidine nucleotides accumulated in erythrocytes of lead workers].
    Sakai T; Takeuchi Y; Ikeya Y; Araki T; Ushio K
    Sangyo Igaku; 1989 Sep; 31(5):372-3. PubMed ID: 2555612
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery.
    Chapman AG; Westerberg E; Siesjö BK
    J Neurochem; 1981 Jan; 36(1):179-89. PubMed ID: 7463044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of activity of erythrocyte pyrimidine 5'-nucleotidase (P5N) in lead exposed workers: with focus on the effect on hemoglobin.
    Kim Y; Yoo CI; Lee CR; Lee JH; Lee H; Kim SR; Chang SH; Lee WJ; Hwang CH; Lee YH
    Ind Health; 2002 Jan; 40(1):23-7. PubMed ID: 11926511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
    Swanson MS; Angle CR; Stohs SJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
    Konantakieti C; Beuthin FC; Louis-Ferdinand RT
    J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y; Hasegawa T; Sugimoto K
    Int Arch Occup Environ Health; 1988; 60(6):431-6. PubMed ID: 2842263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte nucleotide pattern in two children in a Norwegian family with pyrimidine 5'-nucleotidase deficiency.
    Ericson A; de Verdier CH; Hansen TW; Seip M
    Clin Chim Acta; 1983 Oct; 134(1-2):25-33. PubMed ID: 6317231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
    Cook LR; Angle CR; Kubitschek CE; Stohs SJ
    J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead poisoning: association with hemolytic anemia, basophilic stippling, erythrocyte pyrimidine 5'-nucleotidase deficiency, and intraerythrocytic accumulation of pyrimidines.
    Valentine WN; Paglia DE; Fink K; Madokoro G
    J Clin Invest; 1976 Oct; 58(4):926-32. PubMed ID: 965496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.